ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• How MAC Clinical Research Innovates With CDMS/EDC

  Discover how a partnership with one of Europe’s largest contract research organizations exemplifies the crucial role that technology plays in the realm of clinical studies.

• 3 Study Areas Where Your IRT Vendor Should Do More

  Find out how advanced IRT systems now support diverse trial designs and how the expertise of RTSM vendors is crucial for tailoring solutions to trial needs and providing ongoing support.

• How Site eSource Completes And Extends The EHR To EDC Initiative

  This study evaluates to what degree an eSource-to-EDC data transfer initiative succeeds through two key dimensions: "Mappability" and "Prevalence".

• eReg Benefits For Clinical Research: Use Cases For All Types Of Sites

  Unearth the different kinds of eRegulatory use cases for diverse clinical site types and other eRegulatory capabilities designed to serve all sites.

• CRO Takes Trial Build Times From Weeks To Days

  Recognizing the inefficiencies in traditional build processes, a top global CRO partnered with Medable to transform its approach to clinical trial launch.

• The Case For Cognitive Assessments In Phase 1 Clinical Trials

  Regulators prioritize patient-reported outcomes. Cognitive assessments in Phase 1 trials detect early drug-related cognitive effects, ensuring safety and efficacy. Signant’s CDR System® is a proven tool for this.

• eCOA Standards And KPIs To Include In Your Next RFI

  Check out this practical roadmap on vendor selection and learn specific performance metrics and quality benchmarks you should ask your next eCOA partner.

• Nevro Eliminates Majority Of Source Data Verification With ePRO And EDC

  Read how a global medical device company was able to unlock new efficiencies by implementing data collection via electronic patient-reported outcome assessments.

• The Case For A Unified eClinical Platform In Clinical Trials

  Coordinating and centralizing eClinical platform functionality is essential to enabling agility and flexibility in the modern clinical trial landscape.

• How Real-World Data On Site Costs Accelerates Clinical Trial Success

  Outdated budgeting slows oncology trials. Real-world site cost data enables faster planning, smoother startup, and better patient care through smarter, evidence-based financial decisions.